Yidi Wu, PhD, is a Postdoctoral Research Scientist at Eli Lilly and Company, focusing on 2-dimensional liquid chromatography and high-resolution mass spectrometry for analytical method development in RNA therapeutics within Lilly Genetic Medicine since October 2023. Previously, Yidi Wu engaged in various research roles, including as a Graduate Research Assistant at Wake Forest University from August 2018 to July 2022, investigating 3D polymeric and protein-based biomaterials and creating scaffolds for tissue engineering. Other experiences include serving as a Research Scientist at the Indiana Department of Health, a Biologics Process Co-op at Merck, and a Research Associate at OncoPlex Diagnostics, where contributions included proteomic analysis and the translation of cancer biomarkers. Yidi Wu's educational background comprises a PhD in Biomedical/Medical Engineering from Wake Forest University, a Master's degree in Biotechnology from Northwestern University, and a Bachelor's degree in Pharmacy from Nankai University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices